Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma

Niessner, Heike; Huesch, Anna; Kosnopfel, Corinna; Meinhardt, Matthias; Westphal, Dana; Meier, Friedegund; Schilling, Bastian; Sinnberg, Tobias

dc.contributor.author	Niessner, Heike
dc.contributor.author	Sinnberg, Tobias
dc.contributor.author	Hüsch, Anna
dc.date.accessioned	2024-03-04T11:13:05Z
dc.date.available	2024-03-04T11:13:05Z
dc.date.issued	2023
dc.identifier.issn	2072-6694
dc.identifier.uri	http://hdl.handle.net/10900/151448
dc.language.iso	en	de_DE
dc.publisher	Basel : Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/cancers15235521	de_DE
dc.subject.ddc	610	de_DE
dc.title	Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240124000000_00275
utue.personen.roh	Niessner, Heike
utue.personen.roh	Huesch, Anna
utue.personen.roh	Kosnopfel, Corinna
utue.personen.roh	Meinhardt, Matthias
utue.personen.roh	Westphal, Dana
utue.personen.roh	Meier, Friedegund
utue.personen.roh	Schilling, Bastian
utue.personen.roh	Sinnberg, Tobias
dcterms.isPartOf.ZSTitelID	Cancers	de_DE
dcterms.isPartOf.ZS-Issue	Article 5521	de_DE
dcterms.isPartOf.ZS-Volume	15 (23)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE